Our Pricing

Understanding Wegovy Side Effects: What UK Patients Need to Know

Wegovy side effects are a common concern for patients considering this weight loss treatment, yet understanding what to expect can significantly improve your treatment experience. As a UK-registered pharmacy team who has supported thousands of patients through their Wegovy journey, we've seen firsthand that most side effects are manageable and typically diminish within the first few weeks. This comprehensive guide draws on clinical trial data and real patient experiences to help you make an informed decision about Wegovy treatment.

Common Wegovy Side Effects: What Clinical Trials Tell Us

The STEP clinical trial programme, which evaluated semaglutide for weight management in over 4,500 participants, provides robust data on wegovy side effects [1]. The most frequently reported adverse events were gastrointestinal in nature, affecting approximately 44% of participants during the dose escalation phase. These included nausea (experienced by up to 44% of patients), diarrhoea (30%), vomiting (24%), and constipation (24%) [1].

What's particularly reassuring from our clinical experience at Cured Pharmacy is that these wegovy side effects typically peak during the first 4-8 weeks of treatment and significantly diminish as your body adjusts to the medication. The gradual dose escalation schedule built into Wegovy's treatment protocol is specifically designed to minimise these effects. Superintendent pharmacist Tarun Kumar (GPhC 2233073) notes that patients who follow dietary modifications alongside their injections report substantially fewer gastrointestinal symptoms.

Beyond gastrointestinal effects, clinical trials documented other wegovy side effects including headache (14%), fatigue (11%), and dizziness (8%) [1]. Injection site reactions such as mild redness or itching occurred in approximately 5% of patients but were generally mild and self-limiting. It's worth noting that serious adverse events were rare, occurring in less than 2% of trial participants, and most were unrelated to the medication itself.

Managing Wegovy Side Effects: Practical Strategies from UK Pharmacists

Successfully managing wegovy side effects often comes down to implementing targeted lifestyle adjustments during your first month of treatment. For nausea—the most commonly reported side effect—we recommend eating smaller, more frequent meals rather than three large ones, avoiding high-fat and spicy foods, and staying well-hydrated throughout the day [2]. Many of our patients find that taking their injection in the evening after a light meal helps minimise morning nausea.

If you experience constipation as a wegovy side effect, increasing your dietary fibre intake to 25-30g daily and ensuring adequate water consumption (at least 2 litres per day) typically resolves the issue within a few days. For diarrhoea, the opposite approach applies: temporarily reducing high-fibre foods and focusing on bland, easily digestible options like rice, bananas, and toast can provide relief whilst your digestive system adjusts to the medication [2].

Injection technique also plays a crucial role in minimising wegovy side effects, particularly injection site reactions. Rotate your injection sites between your abdomen, thigh, and upper arm, never injecting in the same spot twice in a row. Allow the pen to reach room temperature before injecting, and use a slow, steady injection technique rather than a quick jab. These simple measures can significantly reduce localised discomfort and bruising.

When to Contact Your Healthcare Provider

Whilst most wegovy side effects are manageable at home, certain symptoms warrant immediate medical attention. Contact your prescriber or NHS 111 if you experience severe, persistent abdominal pain (which could indicate pancreatitis), signs of gallbladder problems (pain in the upper right abdomen, yellowing of skin or eyes), or symptoms of thyroid tumours (lump in the neck, difficulty swallowing, persistent hoarseness) [3]. Though these serious side effects are rare, occurring in less than 1% of patients, early recognition is essential.

Additionally, seek medical advice if you experience signs of severe dehydration from persistent vomiting or diarrhoea, including decreased urination, dizziness upon standing, or extreme fatigue. Our clinical team at Cured Pharmacy is available to discuss any concerns during your treatment journey, and all patients receive follow-up support as part of their ongoing care.

Wegovy Side Effects vs Other Weight Loss Medications: A UK Comparison

When comparing wegovy side effects to other GLP-1 receptor agonists available in the UK, the side effect profile is broadly similar across the class. Saxenda (liraglutide), which requires daily injections, shows comparable gastrointestinal side effects but with potentially higher rates of nausea due to its daily dosing schedule rather than Wegovy's once-weekly administration [4]. Many patients transitioning from Saxenda to Wegovy report improved tolerability with the less frequent injection schedule.

Mounjaro (tirzepatide), which combines GLP-1 and GIP receptor agonism, demonstrates a slightly different side effect profile. Whilst gastrointestinal wegovy side effects occur at similar rates, some trial data suggests tirzepatide may cause marginally less nausea but slightly more diarrhoea during the initial weeks [4]. However, both medications share the same gradual dose escalation approach that helps minimise adverse effects.

Compared to orlistat-based treatments like Xenical, wegovy side effects differ substantially. Orlistat primarily causes gastrointestinal effects related to fat malabsorption—including oily stools and increased bowel movements—which persist throughout treatment rather than diminishing over time. Many patients find the temporary nature of Wegovy's side effects more acceptable than the ongoing digestive changes associated with orlistat therapy.

Long-Term Wegovy Side Effects: What UK Clinical Data Shows

Long-term safety data from the STEP trials, which followed patients for up to 68 weeks, provides reassuring evidence about sustained wegovy side effects [5]. The majority of gastrointestinal adverse events occurred during the dose escalation phase (weeks 0-16) and decreased substantially during the maintenance phase. By week 20, only 8% of patients reported ongoing nausea, compared to 44% during initial titration.

Regarding metabolic wegovy side effects, the STEP trials documented a small increase in heart rate averaging 1-4 beats per minute, which remained stable throughout the treatment period [5]. This modest change is not considered clinically significant for most patients but is monitored during ongoing treatment. Blood pressure typically decreased in trial participants, likely secondary to weight loss rather than a direct medication effect.

One area requiring ongoing monitoring involves potential thyroid effects. Whilst medullary thyroid carcinoma was observed in rodent studies, no causal relationship has been established in humans during post-marketing surveillance [3]. Nevertheless, Wegovy remains contraindicated in patients with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2. Our prescribers at Cured Pharmacy carefully screen for these risk factors during the online consultation process.

Cardiovascular Safety Profile

The SELECT cardiovascular outcomes trial demonstrated that semaglutide (Wegovy's active ingredient) reduced major adverse cardiovascular events by 20% in patients with pre-existing cardiovascular disease [6]. This landmark study not only confirmed the absence of concerning cardiovascular wegovy side effects but actually showed protective benefits. For UK patients with obesity and heart disease, this represents a significant safety advantage over older weight loss medications that carried cardiovascular risks.

Minimising Wegovy Side Effects: UK Prescriber Recommendations

Our UK clinical team has developed evidence-based protocols to help patients minimise wegovy side effects from their very first injection. The single most effective strategy is adhering strictly to the dose escalation schedule: starting at 0.25mg weekly for four weeks, then increasing gradually to the maintenance dose of 2.4mg over 16-20 weeks [2]. Patients who attempt to accelerate this schedule invariably experience more severe side effects.

Dietary modifications during the first month of treatment can dramatically reduce gastrointestinal wegovy side effects. We recommend a 'low and slow' eating approach: consuming smaller portions, chewing thoroughly, and eating slowly over 20-30 minutes. Avoiding trigger foods—particularly high-fat meals, spicy dishes, and carbonated beverages—during the initial eight weeks helps your digestive system adapt to Wegovy's appetite-suppressing effects.

Hydration deserves special emphasis when managing wegovy side effects. Semaglutide slows gastric emptying, which can reduce your natural thirst signals even as your body's fluid needs remain constant. We advise patients to drink at least 2-2.5 litres of water daily, spreading intake throughout the day rather than consuming large amounts at once. Adequate hydration prevents constipation, reduces nausea severity, and helps maintain energy levels during treatment.

Accessing Wegovy Side Effects Support Through Cured Pharmacy

At Cured Pharmacy, we recognise that understanding and managing wegovy side effects is crucial to treatment success, which is why we provide comprehensive support throughout your weight loss journey. When you complete your online consultation, our UK-registered prescribers assess not only your suitability for Wegovy but also identify potential risk factors that might increase your likelihood of experiencing side effects. This personalised approach, overseen by superintendent pharmacist Tarun Kumar (GPhC 2233073), ensures you receive tailored advice from day one.

We supply Wegovy at the cheapest UK price of £69.00, with transparent pricing shown before your consultation—no hidden fees or surprise charges. First-time patients save an additional £69.00 with code Weightlossnew, bringing your initial treatment to just £69.00. This includes your medication, clinical consultation, ongoing prescriber support, and discreet next-day delivery to any UK address. All medicines are genuine, UK-licensed products sourced directly from licensed wholesalers.

Managing wegovy side effects becomes significantly easier with proper clinical support. Our team remains available throughout your treatment to answer questions, adjust your dose escalation schedule if needed, and provide evidence-based advice on symptom management. You can contact us at (+44) 116 4646009 or through your patient portal for guidance at any stage of your Wegovy journey. This ongoing support, combined with our commitment to the lowest UK prices, makes Cured Pharmacy the optimal choice for patients seeking both value and comprehensive care.

Starting Your Wegovy Treatment

Beginning Wegovy treatment through Cured Pharmacy takes under three minutes. Complete the online medical consultation, which covers your medical history, current medications, and any factors that might influence wegovy side effects. Our prescribers review your assessment the same day, and if approved, your medication is dispatched for next-day delivery in 100% discreet packaging. You'll receive detailed administration instructions, side effect management guidance, and direct access to our clinical team for any questions that arise during treatment.

Scientific References

1. Wilding, J. P. H., Batterham, R. L., Calanna, S., Davies, M., Van Gaal, L. F., Lingvay, I., ... & Kushner, R. F. (2021). Once-weekly semaglutide in adults with overweight or obesity. New England Journal of Medicine, 384(11), 989-1002. [accessed 15 August 2026]
2. Garvey, W. T., Batterham, R. L., Bhatta, M., Buscemi, S., Christensen, L. N., Frias, J. P., ... & Wharton, S. (2022). Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial. Nature Medicine, 28(10), 2083-2091. [accessed 15 August 2026]
3. Medicines and Healthcare products Regulatory Agency. (2023). Wegovy 0.25 mg solution for injection in pre-filled pen - Summary of Product Characteristics. Electronic Medicines Compendium. [accessed 15 August 2026]
4. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., Wharton, S., Connery, L., Alves, B., ... & Bunck, M. C. (2023). Tirzepatide once weekly for the treatment of obesity. New England Journal of Medicine, 387(3), 205-216. [accessed 15 August 2026]
5. Rubino, D., Abrahamsson, N., Davies, M., Hesse, D., Greenway, F. L., Jensen, C., ... & Wadden, T. A. (2021). Effect of continued weekly subcutaneous semaglutide vs placebo on weight loss maintenance in adults with overweight or obesity: the STEP 4 randomized clinical trial. JAMA, 325(14), 1414-1425. [accessed 15 August 2026]
6. Lincoff, A. M., Brown-Frandsen, K., Colhoun, H. M., Deanfield, J., Emerson, S. S., Esbjerg, S., ... & Ryan, D. H. (2023). Semaglutide and cardiovascular outcomes in obesity without diabetes. New England Journal of Medicine, 389(24), 2221-2232. [accessed 15 August 2026]
7. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 15 August 2026.
8. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 15 August 2026.
9. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 15 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.